<SEC-DOCUMENT>0000899243-20-021676.txt : 20200806
<SEC-HEADER>0000899243-20-021676.hdr.sgml : 20200806
<ACCEPTANCE-DATETIME>20200806192722
ACCESSION NUMBER:		0000899243-20-021676
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200806
FILED AS OF DATE:		20200806
DATE AS OF CHANGE:		20200806

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			GOETTLER MICHAEL
		CENTRAL INDEX KEY:			0001745691

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-56114
		FILM NUMBER:		201083346

	MAIL ADDRESS:	
		STREET 1:		235 EAST 42ND STREET
		CITY:			NEW YORK
		STATE:			NJ
		ZIP:			10017

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Upjohn Inc
		CENTRAL INDEX KEY:			0001792044
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				834364296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		235 EAST 42ND STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		(212) 733-2323

	MAIL ADDRESS:	
		STREET 1:		235 EAST 42ND STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2020-08-06</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001792044</issuerCik>
        <issuerName>Upjohn Inc</issuerName>
        <issuerTradingSymbol>VTRS</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001745691</rptOwnerCik>
            <rptOwnerName>GOETTLER MICHAEL</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O UPJOHN INC.</rptOwnerStreet1>
            <rptOwnerStreet2>235 EAST 42ND STREET</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10017</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>President</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock, par value $0.01 per share</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes></footnotes>

    <remarks>1. On August 6, 2020, Pfizer Inc. (&quot;Pfizer&quot;) made available to its shareholders an information statement with respect to the distribution of shares of common stock of Upjohn Inc. (&quot;Upjohn&quot;) to Pfizer stockholders. Upjohn previously filed with the U.S. Securities and Exchange Commission a preliminary version of the information statement as part of a registration statement on Form 10 which became effective on June 30, 2020.

No securities are beneficially owned.</remarks>

    <ownerSignature>
        <signatureName>/s/ Susan E. Grant, by power of atty., for Michael Goettler</signatureName>
        <signatureDate>2020-08-06</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>2
<FILENAME>attachment1.htm
<DESCRIPTION>EX-24.1 DOCUMENT
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY>
<PRE>

                                  POWER OF ATTORNEY

The undersigned hereby constitutes and appoints each of Tara J. Gabbai, Susan E.
Grant, Lori P. Hernando, Margaret M. Madden, Madelyn D. Purcell and Shehzad
Siddiqui as the undersigned's true and lawful attorney-in-fact and agent, and
grants each of them full power to act on behalf of the undersigned and in the
undersigned's name, place and stead, in any and all capacities, for the
purpose of completing and signing, on behalf of the undersigned,

     *   any Form 3, Form 4 or Form 5 required or permitted to be filed by the
         undersigned pursuant to Section 16 of the Securities Exchange Act of
         1934, as amended (the "Exchange Act"), and *

     *   any and all other documents, including, without limitation, Form ID,
         necessary or desirable to facilitate the filing by the undersigned of
         forms under Section 16 of the Exchange Act,

with regard to the undersigned's ownership of or transactions in securities of
Upjohn Inc., including, without limitation, the power to complete and sign any
and all amendments to such forms and documents, if any, and to file such forms
and documents and amendments thereto with the Securities and Exchange
Commission, and to do and perform each and every act and thing requisite or
necessary to be done in connection with such forms and documents and amendments
thereto, as fully and to all intents and purposes as the undersigned might or
could do in person.

The authority of Tara J. Gabbai, Susan E. Grant, Lori P. Hernando, Margaret M.
Madden, Madelyn D. Purcell and Shehzad Siddiqui under this Power of Attorney
shall continue until the undersigned is no longer required to file Form 3, Form
4 or Form 5 with regard to the undersigned's ownership of or transactions in
securities of Upjohn Inc., unless earlier revoked in writing.  The undersigned
acknowledges that Tara J. Gabbai, Susan E. Grant, Lori P. Hernando, Margaret M.
Madden, Madelyn D. Purcell and Shehzad Siddiqui are not assuming any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.

 /s/ Michael Goettler
-------------------------------
Michael Goettler



</PRE>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
